Research Insight

The pharmaceutical sector stands at a very critical crossroads in which the traditional reliance on randomized control trials (RCTs) alone is no longer sufficient when it comes to comprehensive understanding of drug performance. The Pharmaceutical Efficacy-Effectiveness Gap that the...

Researchers have gone on to demonstrate that microscopic drug delivery containers can get magnetically steered to their objectives, thereby advancing the development when it comes to precision medicine for the treatment of diseases like cancer. A multi-university team, which...

Dual-active material science solution is ideal for sensitive formulations Auburn, AL, July 8, 2025 – Aptar CSP Technologies, part of AptarGroup, Inc. and a leader in active material science, today announced that it has developed a dual-active material science technology...

The biopharmaceutical industry in the Asia-Pacific area has seen a significant strategic shift in recent years; this trend is now commonly acknowledged as Asia's bio sovereignty movement. Countries like China, India, Japan, South Korea, and Singapore are making daring...

The struggle to get new medications onto the market is more intense than ever in the rapidly evolving pharmaceutical industry of today. Separated into sequential segments, the traditional drug development process can be costly and time-consuming. Converging drug material...

The pharmaceutical manufacturing spectrum is going through a profound shift with contract development manufacturing organizations (CDMOs) transitioning from just being simple capacity providers to becoming strategic partners. This shift comes as pharmaceutical companies face very intense pressure in order to...

Artificial intelligence has rapidly evolved from academic theory into a transformative force in pharmaceutical R&D. From early QSAR models to neural networks, and now to AlphaFold3, AI has progressively unlocked deeper biological insights. By integrating structure prediction, molecular modeling,...